Acute myeloid leukaemia
RecruitingVenetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia
Venetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia
- Disease:Acute myeloid leukaemia
- Substances:AzacitidineCytarabine+3
The Netherlands- Participants:0–17 years · 18–64 years
- Substances:Azacitidine
- Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.










